openPR Logo
Press release

GCC Oncology/Cancer Drugs Market Revenue, Key Findings and Forecast 2020-2025 | Pfizer International Corporation, Bayer Middle East FZE, Amgen, Inc.

08-23-2022 02:32 PM CET | Health & Medicine

Press release from: MarkNtel Advisors LLP

GCC Oncology/Cancer Drugs Market Revenue, Key Findings

The latest research report on the GCC Oncology/Cancer Drugs Market by MarkNtel Advisors drafts an extensively detailed analysis of the different trends, drivers, restraints, challenges, and opportunities for the stakeholders to make informed decisions in the future. The report is to benefit the leaders by using the integrated market report using the advantageous information, including the impact of Covid-19. While the pandemic affected the world drastically and has brought along various changes in market conditions, the rapidly changing dynamics of the market in the historic, current, and future times are evaluated in the report.

The study is also a combination of analysis of the market statistics, growth, growing competition analysis, investment opportunities, prominent players, industry facts, statistical figures, revenues, sales & profit, and gross margins of the GCC Oncology/Cancer Drugs Market. Nonetheless, the business strategies, market shares, top lucrative regions, upsurging product/service demand, & recent developments are also incorporated in the market report by the research analysts of MarkNtel Advisors.

Request Sample Report of GCC Oncology/Cancer Drugs Market: - https://www.marknteladvisors.com/query/request-sample/gcc-oncology-cancer-drugs-market.html

What Information does this report contain?

Composition of the Research Report on the GCC Oncology/Cancer Drugs Market
• The analysis of the previous year generated in the historic years of 2015-18, the existing scenario, trends, & ongoing statistics of the market in the base year 2020, & estimation of the prospect of the market during the forecast period of 2020-25
• The analysis on the development, rise & falls, new entrants, mergers & acquisitions, among other facts across different segmentations & regions/countries, are also comprehensively covered in the market.
• The expert analysis of the key trends in the industry, innovation & technological developments, along with factors restraining & challenging the market expansion, is also integrated into the report using tools like SWOT (Strength, Weakness, Opportunity, &Threat), PESTEL (Political, Economic, Social, Technological, Environmental, & Legal), and Porter's Fiver Forces Model.

Competitive Landscape in the GCC Oncology/Cancer Drugs Market: -
The research report by MarkNtel Advisors drafts unbiased & straightforward analysis of different parameters of the leading players in the complete company profiling, covering the following:
• Business Strategy
• Company Overview
• Financial Performance
• Key Product/Service Offerings
• Performance Indicators
• Porter's Five Forces Model
• Risk Analysis
• Recent Developments
• Regional Presence
• SWOT Analysis

The most prominent players in the GCC Oncology/Cancer Drugs Market are: -
• Hoffmann-La Roche Ltd.
• Johnson & Johnson Middle East FZ LLC
• Pfizer International Corporation
• Merck Serono Middle East FZ-Ltd.
• AbbVie Biopharmaceuticals GmbH
• AstraZeneca Gulf FZ LLC
• Bayer Middle East FZE
• Amgen, Inc.
• Astellas MENA/SSA

For in-depth competitive analysis Visit: - https://www.marknteladvisors.com/research-library/gcc-oncology-cancer-drugs-market.html

Segmentation Analysis:
The research report on the GCC Oncology/Cancer Drugs Market by MarkNtel Advisors depicts that the industry is highly fragmented and has multiple bifurcations. The reports demonstrate detailed researched information on each segment across different geographical locations to provide precise & accurate data on the actual size & volume. The prominent segmentation of the GCC Oncology/Cancer Drugs Market is done in the following way:

Based on, By Therapy
- Chemotherapy
- Immunotherapy
- Targeted Therapy
- Radiation
- Surgical
- Others

Based on, By Application
- Breast Cancer
- Lung Cancer
- Kidney Cancer
- Liver cancer
- Ovarian Cancer
- Prostate Cancer
- Skin Cancer
- Pancreatic Cancer
- Colorectal
- Blood Cancer
- Others

Alongside that, on the geographical front, the GCC Oncology/Cancer Drugs Market expands across the following regions/countries:
• UAE
• Saudi Arabia
• Oman
• Bahrain
• Kuwait
• Qatar

Scope of the GCC Oncology/Cancer Drugs Market Report:
• The research report offers a comprehensive insight into defining, describing, and forecasting the dynamics of the GCC Oncology/Cancer Drugs Market across different segmentations & regions.
• The study drafts a complete computation of the key strategies, developments, trends, profits, and other schemes of the leading players.
• Additionally, the report showcases the effects of the Covid-19 pandemic on the GCC Oncology/Cancer Drugs Market and the leading players & stakeholders involved, witnessing the fluctuations amidst the crisis.
• The researchers at the MarkNtel Advisors are using exhaustive tools for the computation & study of the external environmental effects of the market.
• The core aim of the report is also to deliver the stakeholder insights on the opportunities & provide crucial details about the competitive landscape for the forecast years.

Request for Report Customization: - https://www.marknteladvisors.com/query/request-customization/gcc-oncology-cancer-drugs-market.html

Read our Latest Blog
• Telematics and its Impact on Car Insurance Policies:- https://newscluster24.com/telematics-and-its-impact-on-car-insurance-policies/
• Is CAR T-Cell Therapy the future of Cancer Treatment?:- https://newscollectiononlines.blogspot.com/2022/08/is-car-t-cell-therapy-future-of-cancer.html
• What's in the future for Non-Small Cell Lung Cancer Research & Treatment?:- https://newscluster24.com/whats-in-the-future-for-non-small-cell-lung-cancer-research-treatment/

Contact Us:
MarkNtel Advisors
Email: sales@marknteladvisors.com
Call - +1 604 1900 2671
Website: www.marknteladvisors.com

MarkNtel Advisors is a leading research, consulting, and data analytics firm that provides a wide range of strategic reports on diverse industry verticals to a substantial and varied client base that includes multinational corporations, financial institutions, governments, and individuals.

We specialize in niche industries and emerging geographies to support our clients in the formulation of strategies viz. Go to Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, trend analysis, etc. in around 15 industry verticals to enable our clients in identifying attractive investment opportunities and maximizing ROI through an early mover advantage.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release GCC Oncology/Cancer Drugs Market Revenue, Key Findings and Forecast 2020-2025 | Pfizer International Corporation, Bayer Middle East FZE, Amgen, Inc. here

News-ID: 2713360 • Views:

More Releases from MarkNtel Advisors LLP

Saudi Arabia Halal Food Market Poised for Growth: 6.48% CAGR Forecasted Through 2030
Saudi Arabia Halal Food Market Poised for Growth: 6.48% CAGR Forecasted Through …
Introduction The Saudi Arabia Halal Food Market is on the rise, expected to reach a market size of USD 63.28 billion by 2030, growing from USD 46.22 billion in 2025. Driven by a compound annual growth rate (CAGR) of approximately 6.48%, this growth is bolstered by several key factors, including a predominantly Muslim population, robust government support, an expanding retail sector, and a surge in tourism and hospitality. The evolving consumer
Saudi Arabia Energy Management Market Set to Achieve 11.67% CAGR by 2030 Driven by Government Incentives
Saudi Arabia Energy Management Market Set to Achieve 11.67% CAGR by 2030 Driven …
Introduction The Saudi Arabia Energy Management Market is evolving rapidly, valued at approximately USD 298 million in 2025, with a robust compound annual growth rate (CAGR) of 11.67% anticipated until 2030. This impressive growth trajectory is significantly driven by the Saudi government's vigorous agenda promoting energy efficiency, the increasing integration of renewable energy sources, and advancements in technology, such as artificial intelligence. As the nation shifts towards smarter energy consumption practices,
GCC Ginger Market Revenue Expected to Reach USD 122 Million by 2030 | Major Players Include Agthia Group and Al Islami Foods
GCC Ginger Market Revenue Expected to Reach USD 122 Million by 2030 | Major Play …
Executive Summary The GCC Ginger Market is poised for robust growth, driven by increasing health consciousness and a diverse expatriate population. Valued at approximately USD 88.29 million in 2025, the market is projected to reach USD 122 million by 2030, reflecting a Compound Annual Growth Rate (CAGR) of 6.68% from 2025 to 2030. Key government initiatives aiming at promoting healthier lifestyles further bolster this trend, positioning ginger as a staple in
Asia-Pacific Ginger Market to Reach USD 2.55 Billion by 2030 | Key Players Included: Allana Group, Buderim Ginger Ltd., and Mane Kancor
Asia-Pacific Ginger Market to Reach USD 2.55 Billion by 2030 | Key Players Inclu …
Executive Summary The Asia-Pacific Ginger Market is poised for significant growth, with a projected size of USD 2.55 billion by 2030, up from USD 1.89 billion in 2025. This growth trajectory reflects a compound annual growth rate (CAGR) of 6.17% from 2025 to 2030, driven by increasing consumer awareness about health benefits, government support initiatives, and a growing demand for organic products. The region's climatic advantages further enhance ginger cultivation, ensuring

All 5 Releases


More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boost
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports. Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For